FDA APPROVES NEW SPARKLE FOR Rx DRUGS

SEPTEMBER 01, 2006

The FDA has approved new pharmaceutical pigmentation rules that are likely to give extra sparkle to the pills and tablets dispensed by American pharmacists. Under the new regulations, manufacturers will be allowed to use "pearlescent pigments" in virtually all oral human drugs, including tablets, pills, and liquids. Similar to the coloring agents used in many cosmetics, the new pigments can produce metallic or satiny finishes on drugs and can even be used to provide extra coloring.

The pigments are made by coating the mineral mica with either titanium dioxide or iron oxide—substances used to add luster to everything from lipstick to automobile paint. Under the new rules, the pigments cannot make up more than 3% of the weight of a drug.

According to the FDA, "there is no toxic potential when [pigments are] ingested at levels estimated by the agency."



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.